Opportunity Information: Apply for RFA CA 18 021
This grant opportunity (RFA-CA-18-021) from the National Institutes of Health, through the National Cancer Institute (NCI), is designed specifically for investigators who already hold an active NCI-supported R01 award and want to submit a revision application (often called a supplement or competitive revision) that expands their currently funded project. The central purpose is to add new, clearly defined research directions that align with the NCI's "Provocative Questions" (PQs), a set of high-priority scientific questions intended to push the cancer research field toward areas where progress has been slow or where new approaches could unlock major advances.
A key feature of the FOA is that it does not fund an entirely new, stand-alone project. Instead, applicants must propose additional specific aims that build directly on the parent R01 and expand its scope in a logical, well-justified way. In practical terms, the revision should show a tight connection to the existing funded work (shared scientific premise, resources, and expertise) while adding new aims that directly address one of the 12 PQs referenced in the related announcements for new applications (RFA-CA-18-019 for R01s and RFA-CA-18-020 for R21s). The emphasis is on being PQ-driven: the new work should be clearly mapped to one PQ and demonstrate how the added aims will generate meaningful progress on that question.
Beyond simply conducting new PQ-related experiments, the FOA explicitly encourages projects that help validate the outcomes of prior PQ research or that focus on adoption, dissemination, or translation of PQ-generated findings in ways that could influence cancer research directions and clinical care. This means the opportunity can support a range of activities as long as they are research-based and tied to the PQ framework, including efforts that strengthen evidence, improve reproducibility, or move promising findings closer to real-world impact. Clinical trials are optional under this announcement, so applicants may propose clinical trial activities if they are appropriate for the aims, but they are not required.
The opportunity is categorized as a discretionary grant program within NIH's health and education activity areas and is associated with multiple CFDA numbers (93.393, 93.394, 93.395, 93.396, and 93.399), reflecting NCI's broader research funding authorities. The stated award ceiling is $150,000, which suggests the revision budget is intended to be relatively targeted and additive rather than a major expansion equivalent to a full new grant. The original closing date listed is October 30, 2018, and the FOA was created on April 3, 2018, indicating it was a time-limited solicitation with defined submission timing.
Eligibility is broad in terms of institution types, but the applicant must have an active NCI R01 to serve as the parent award for the revision. Eligible applicant organizations include various levels of government (state, county, city/township, and special district), public and private institutions of higher education, independent school districts, public housing authorities/Indian housing authorities, federally recognized Native American tribal governments and other tribal organizations, nonprofits with and without 501(c)(3) status, for-profit organizations (other than small businesses), and small businesses. The FOA also highlights additional eligible applicants such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, U.S. territories or possessions, regional organizations, eligible federal agencies, and even non-U.S. (foreign) entities. In short, many organizational types can apply, but the revision mechanism anchors eligibility to the existence of an active NCI R01 that will be expanded through new PQ-focused aims.
Overall, this FOA is best understood as an NCI strategy to accelerate progress on its Provocative Questions by leveraging ongoing R01-funded research programs. Rather than waiting for entirely new grants to start from scratch, it encourages established R01 teams to add well-integrated, incremental but high-impact aims that tackle specific PQ challenges, strengthen or validate emerging results, and potentially speed the path from discovery to broader research use and clinical relevance.Apply for RFA CA 18 021
- The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Revision Applications to National Cancer Institute (NCI) Supported R01 Awards to Include Research on the NCIs Provocative Questions (R01 Clinical Trial Optional)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.393, 93.394, 93.395, 93.396, 93.399.
- This funding opportunity was created on 2018-04-03.
- Applicants must submit their applications by 2018-10-30. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $150,000.00 in funding.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQ) - RFA-CA-18-021 (NCI Provocative Questions Revision to Active NCI R01)
What is RFA-CA-18-021 intended to support?
RFA-CA-18-021 is an NIH/NCI funding opportunity designed to support revision applications to an already active, NCI-supported R01 award. The goal is to expand the scope of the currently funded R01 by adding new, clearly defined research directions that directly align with the National Cancer Institute's Provocative Questions (PQs).
Is this opportunity for a brand-new, stand-alone research project?
No. This funding opportunity does not support an entirely new, stand-alone project. It is specifically for a revision (often described as a supplement or competitive revision) to an existing NCI-funded R01, where the applicant adds new specific aims that build directly on the parent award.
Who can apply for this grant opportunity?
Applicants must have an active NCI-supported R01 award that will serve as the parent grant for the revision application. While institutional eligibility is broad, the key eligibility anchor is the existence of an active NCI R01 to be expanded through PQ-focused additional aims.
What types of organizations are eligible to apply?
Eligible applicant organizations include (as described in the opportunity) state governments, county governments, city or township governments, special district governments, public and private institutions of higher education, independent school districts, public housing authorities/Indian housing authorities, federally recognized Native American tribal governments and other tribal organizations, nonprofits with and without 501(c)(3) status, for-profit organizations (other than small businesses), and small businesses.
Are any additional organization categories specifically highlighted as eligible?
Yes. The opportunity also highlights eligibility for Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, U.S. territories or possessions, regional organizations, eligible federal agencies, and non-U.S. (foreign) entities, provided the application is anchored to an active NCI R01 parent award.
What is meant by a "revision application" in this FOA?
In this context, a revision application is a request to expand the scope of the currently funded NCI R01 by adding new specific aims. The new work should be a logical, well-justified extension of the parent R01 rather than a separate research program.
How closely must the proposed new work connect to the parent R01?
The proposed additional aims should show a tight connection to the existing funded work, including a shared scientific premise and use of existing resources and expertise. The revision is expected to expand the scope in an integrated way, rather than branching into unrelated work.
What are the NCI "Provocative Questions" (PQs) and why do they matter here?
The Provocative Questions are high-priority scientific questions identified by NCI to push cancer research into areas where progress has been slow or where new approaches could unlock major advances. This FOA emphasizes that the added aims in the revision must be PQ-driven and clearly mapped to one of the referenced PQs.
How many Provocative Questions must the revision address?
Based on the information provided, the emphasis is on mapping the new work clearly to one PQ and demonstrating how the added aims will generate meaningful progress on that question.
Where are the Provocative Questions referenced for this FOA?
The FOA references the Provocative Questions as described in related announcements for new applications: RFA-CA-18-019 (R01s) and RFA-CA-18-020 (R21s). The revision under RFA-CA-18-021 should align the new aims with one of the 12 PQs referenced in those related announcements.
What kinds of activities does the FOA encourage beyond new experiments?
In addition to conducting PQ-related research, the FOA explicitly encourages projects that help validate outcomes of prior PQ research and projects focused on adoption, dissemination, or translation of PQ-generated findings in ways that could influence cancer research directions and clinical care. Activities can include efforts that strengthen evidence, improve reproducibility, or move promising findings closer to real-world impact, as long as they are research-based and tied to the PQ framework.
Are clinical trials required under this opportunity?
No. Clinical trials are optional under this announcement. Applicants may propose clinical trial activities if appropriate for the aims, but clinical trials are not required.
What is the maximum award amount for this FOA?
The stated award ceiling is $150,000. This suggests the revision budget is intended to be targeted and additive rather than comparable to a full new grant.
When was this funding opportunity created and when did it close?
The FOA was created on April 3, 2018, and the original closing date listed is October 30, 2018, indicating it was a time-limited solicitation with defined submission timing.
Which agency is offering this funding opportunity?
This opportunity is offered by the National Institutes of Health (NIH) through the National Cancer Institute (NCI).
How is this opportunity categorized within federal funding program areas?
The opportunity is categorized as a discretionary grant program within NIH's health and education activity areas.
Which CFDA numbers are associated with this funding opportunity?
The opportunity is associated with multiple CFDA numbers: 93.393, 93.394, 93.395, 93.396, and 93.399, reflecting NCI's broader research funding authorities.
What is the overall strategy behind this FOA?
The FOA represents an NCI strategy to accelerate progress on the Provocative Questions by leveraging ongoing R01-funded research programs. Rather than funding a separate, new project, it encourages established R01 teams to add well-integrated new aims that tackle specific PQ challenges and potentially speed the path from discovery to broader research use and clinical relevance.
Does this FOA require that the parent award be specifically funded by NCI?
Yes. The opportunity is designed specifically for investigators who already hold an active NCI-supported R01 award and want to submit a revision application expanding that currently funded project.
What makes a revision application responsive to this FOA?
Based on the information provided, a responsive revision would (1) be tied to an active NCI R01 parent award, (2) add new, clearly defined specific aims that build directly on the parent project, and (3) be clearly PQ-driven by mapping the added aims to one Provocative Question and showing how the new work will advance progress on that question.
Browse more opportunities from the same category: Education, Health
Next opportunity: Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed)
Previous opportunity: Fiscal Year 2018 Chesapeake Bay Fisheries Research Program
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA CA 18 021
Applicants also applied for:
Applicants who have applied for this opportunity (RFA CA 18 021) also looked into and applied for these:
| Funding Opportunity |
|---|
| Exploring Epigenomic or Non-Coding RNA Regulation in the Development, Maintenance, or Treatment of Chronic Pain (R61/R33 Clinical Trial Optional) Apply for PAR 18 742 Funding Number: PAR 18 742 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Revision Applications to National Cancer Institute (NCI)-supported P01 Awards to Include Research on the NCIs Provocative Questions (P01 Clinical Trial Optional) Apply for RFA CA 18 023 Funding Number: RFA CA 18 023 Agency: National Institutes of Health Category: Education, Health Funding Amount: $150,000 |
| NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional) Apply for PAR 18 746 Funding Number: PAR 18 746 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
| Research Supplements to Promote Data Sharing in Cancer Epidemiology Studies (Admin Supp Clinical Trial Not Allowed) Apply for PA 18 748 Funding Number: PA 18 748 Agency: National Institutes of Health Category: Education, Health Funding Amount: $150,000 |
| Harnessing Big Data to Halt HIV (R01 Clinical Trial Optional) Apply for PAR 18 764 Funding Number: PAR 18 764 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) (Collaborative U54 Clinical Trial Optional) Apply for PAR 18 767 Funding Number: PAR 18 767 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Pilot and Feasibility Studies in Preparation for Drug and Alcohol Abuse Prevention Trials (R34 Clinical Trial Optional) Apply for PA 18 775 Funding Number: PA 18 775 Agency: National Institutes of Health Category: Education, Health Funding Amount: $225,000 |
| Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 Clinical Trial Optional) Apply for PA 18 774 Funding Number: PA 18 774 Agency: National Institutes of Health Category: Education, Health Funding Amount: $225,000 |
| Maternal Nutrition and Pre-pregnancy Obesity: Effects on Mothers, Infants and Children (R01 Clinical Trial Optional) Apply for PA 18 776 Funding Number: PA 18 776 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| International Research Collaboration on Drug Abuse and Addiction Research (R01 Clinical Trial Optional) Apply for PA 18 773 Funding Number: PA 18 773 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Investigation of the Transmission of Kaposi Sarcoma-Associated Herpesvirus (KSHV) (R21 Clinical Trial Not Allowed) Apply for RFA CA 18 014 Funding Number: RFA CA 18 014 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Investigation of the Transmission of Kaposi Sarcoma-associated Herpesvirus (KSHV)(R01 Clinical Trial Optional) Apply for RFA CA 18 013 Funding Number: RFA CA 18 013 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
| Precision Imaging of Oral Lesions (R01- Clinical Trial Not Allowed) Apply for PAR 18 787 Funding Number: PAR 18 787 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Genetic analysis of non-human animal models to understand the genomic architecture of substance use disorders and addictive behaviors (U01 Clinical Trial Not Allowed) Apply for PAR 18 789 Funding Number: PAR 18 789 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Computational Approaches to Curation at Scale for Biomedical Research Assets (R01 Clinical Trial Not Allowed) Apply for PAR 18 796 Funding Number: PAR 18 796 Agency: National Institutes of Health Category: Education, Health Funding Amount: $250,000 |
| Cancer Prevention, Diagnosis, and Treatment Technologies for Low-Resource Settings (R41/R42 - Clinical Trial Optional) Apply for PAR 18 802 Funding Number: PAR 18 802 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Cancer Prevention, Diagnosis, and Treatment Technologies for Low-Resource Settings (R43/R44 - Clinical Trial Optional) Apply for PAR 18 801 Funding Number: PAR 18 801 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Administrative Supplements to Promote Diversity in Small Businesses-SBIR/STTR (Admin Supp Clinical Trial Not Allowed) Apply for PA 18 837 Funding Number: PA 18 837 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Collaborative Human Tissue Network (CHTN) (UM1 Clinical Trials Not Allowed) Apply for RFA CA 18 025 Funding Number: RFA CA 18 025 Agency: National Institutes of Health Category: Education, Health Funding Amount: $800,000 |
| Administrative Supplements to Support Cancer Disparity Collaborative Research (Clinical Trial Optional) Apply for PA 18 842 Funding Number: PA 18 842 Agency: National Institutes of Health Category: Education, Health Funding Amount: $150,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA CA 18 021", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
